Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Invest New Drugs. 2012 May 22;31(2):345–354. doi: 10.1007/s10637-012-9820-z

Table 1. Baseline demographics and patient characteristics.

Characteristic n %

Sex
 Male 12 67
 Female 6 33

Age, years
 Median 56.5
 Range 38 - 75

ECOG performance status
 0 6 33
 1 12 67

KRAS Status
 Wild type 6 33
 Mutated 6 33
 Unknown 6 33

Previous lines of systemic therapies
 Median 2.5
 Range 1 - 6

Previous therapy
 Chemotherapy 18 100
 Radiotherapy 7 39

Abbreviations: ECOG, Eastern Cooperative Oncology Group;